Toggle navigation
Home
Search
Services
Blog
Contact
About
Human Monoclonal Antibodies
Hwang, Kou M.
Genelabs Technologies, Inc., Redwood City, CA, United States
Search 5 grants from Kou Hwang
Search grants from Genelabs Technologies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Morphodynamic Profiling Angiogenesis in 3D
Emotional Competence, Poverty, and Mental Health
Conjugal Transfer of Bacteroides Antibiotic Resistances
Arkansas Cancer Research Center
Dermal Absorption of Diethanolamine and Triethanolamine in Rats and Mice
Recently added grants:
Transcriptomic and epigenomic landscape of neurodegenerative disease models
A large animal model to elucidate the role of LGR5 stem cells in cancer
Characterizing malaria vector competence among natural populations of Anopheles
Optical nanosensor for 3D force sensing in intact tissues of live animals
PD-L1 inhibition promotes type I interferon responses, enhancing chemotherapy-induced cytotoxicity in cancer cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067938-001
Application #
3614576
Study Section
Project Start
1986-09-18
Project End
Budget Start
1986-11-01
Budget End
1987-03-31
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Genelabs Technologies, Inc.
Department
Type
DUNS #
City
Redwood City
State
CA
Country
United States
Zip Code
94063
Related projects
NIH 1987
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
NIH 1986
N43 CM
Human Monoclonal Antibodies
Hwang, Kou M. / Genelabs Technologies, Inc.
Comments
Be the first to comment on this grant